• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米疫苗在自身免疫性疾病中的应用。

The Application of Nanovaccines in Autoimmune Diseases.

机构信息

Department of Dermatology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, People's Republic of China.

出版信息

Int J Nanomedicine. 2024 Jan 12;19:367-388. doi: 10.2147/IJN.S440612. eCollection 2024.

DOI:10.2147/IJN.S440612
PMID:38229706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10790641/
Abstract

Autoimmune diseases are diseases caused by the body's chronic immune responses to self-antigens and attacks on the host's own cells, tissues and organs. The dysfunction of innate immunity and adaptive immunity leads to the destruction of autoimmune tolerance, which is the most basic factor leading to pathogenesis. The optimal strategy for autoimmune diseases is to modify the host immune system to restore tolerance. The ideal effect of therapeutic autoimmune diseases is to eliminate the autoantigen-specific spontaneous immune response without interfering with the immune response against other antigens. Therapeutic nanovaccines that produce immune tolerance conform to this principle. Nanomaterials provide a platform for antigen loading and modification due to their unique physical and chemical properties. Nanovaccines based on nanomaterial technology can simultaneously enable antigens and adjuvants to be absorbed by immune cells and induce rapid and durable immunity. Nanovaccines have the advantages of being able to be designed and loaded and of better protecting antigens from premature degradation. Nanovaccines also have the ability to target specific tissues or cells through optimized design. We review the latest research progress of nanovaccines for autoimmune diseases and the design strategies of nanovaccines to promote the development of more effective nanovaccines for autoimmune diseases.

摘要

自身免疫性疾病是由机体对自身抗原的慢性免疫反应和对宿主自身细胞、组织和器官的攻击引起的疾病。固有免疫和适应性免疫功能障碍导致自身免疫耐受破坏,这是导致发病机制的最基本因素。治疗自身免疫性疾病的最佳策略是修饰宿主免疫系统以恢复耐受。治疗性自身免疫疾病的理想效果是消除针对自身抗原的自发性免疫反应,而不干扰针对其他抗原的免疫反应。产生免疫耐受的治疗性纳米疫苗符合这一原则。由于纳米材料具有独特的物理和化学性质,因此为抗原负载和修饰提供了平台。基于纳米材料技术的纳米疫苗能够使抗原和佐剂同时被免疫细胞吸收,并诱导快速和持久的免疫。纳米疫苗具有可设计和加载的优点,并且能够更好地保护抗原免受过早降解。纳米疫苗还能够通过优化设计靶向特定组织或细胞。我们综述了自身免疫性疾病纳米疫苗的最新研究进展和纳米疫苗的设计策略,以促进更有效的自身免疫性疾病纳米疫苗的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/7f45cee80030/IJN-19-367-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/ad772cafc00a/IJN-19-367-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/1927024beb20/IJN-19-367-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/2b0e0cc4b8d3/IJN-19-367-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/8b2573882fb3/IJN-19-367-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/7f45cee80030/IJN-19-367-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/ad772cafc00a/IJN-19-367-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/1927024beb20/IJN-19-367-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/2b0e0cc4b8d3/IJN-19-367-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/8b2573882fb3/IJN-19-367-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8b/10790641/7f45cee80030/IJN-19-367-g0005.jpg

相似文献

1
The Application of Nanovaccines in Autoimmune Diseases.纳米疫苗在自身免疫性疾病中的应用。
Int J Nanomedicine. 2024 Jan 12;19:367-388. doi: 10.2147/IJN.S440612. eCollection 2024.
2
Advancements in prophylactic and therapeutic nanovaccines.预防性和治疗性纳米疫苗的进展。
Acta Biomater. 2020 May;108:1-21. doi: 10.1016/j.actbio.2020.03.020. Epub 2020 Apr 5.
3
Therapeutic potential of tolerance-based peptide vaccines in autoimmune diseases.基于耐受的肽疫苗在自身免疫性疾病中的治疗潜力。
Int Immunopharmacol. 2023 Mar;116:109740. doi: 10.1016/j.intimp.2023.109740. Epub 2023 Jan 23.
4
Recent progress in application of nanovaccines for enhancing mucosal immune responses.纳米疫苗在增强黏膜免疫反应应用方面的最新进展。
Acta Pharm Sin B. 2023 Jun;13(6):2334-2345. doi: 10.1016/j.apsb.2022.08.010. Epub 2022 Aug 21.
5
Self-adjuvanting cancer nanovaccines.自佐剂化癌症纳米疫苗。
J Nanobiotechnology. 2022 Jul 26;20(1):345. doi: 10.1186/s12951-022-01545-z.
6
Nanomaterials for antigen-specific immune tolerance therapy.用于抗原特异性免疫耐受治疗的纳米材料。
Drug Deliv Transl Res. 2023 Jul;13(7):1859-1881. doi: 10.1007/s13346-022-01233-3. Epub 2022 Sep 12.
7
Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.免疫调节剂对自身免疫性疾病疫苗诱导反应的影响。
Autoimmunity. 2017 Nov;50(7):393-402. doi: 10.1080/08916934.2017.1373766. Epub 2017 Sep 14.
8
Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy.单磷酰脂质 A 组装的纳米疫苗增强肿瘤免疫治疗。
Acta Biomater. 2023 Nov;171:482-494. doi: 10.1016/j.actbio.2023.09.013. Epub 2023 Sep 13.
9
Harnessing the liver to induce antigen-specific immune tolerance.利用肝脏诱导抗原特异性免疫耐受。
Semin Immunopathol. 2022 Jul;44(4):475-484. doi: 10.1007/s00281-022-00942-8. Epub 2022 May 5.
10
Nanovaccines: A game changing approach in the fight against infectious diseases.纳米疫苗:抗击传染病的变革性方法。
Biomed Pharmacother. 2023 Nov;167:115597. doi: 10.1016/j.biopha.2023.115597. Epub 2023 Sep 30.

引用本文的文献

1
New insights for the development of efficient DNA vaccines.为开发高效的 DNA 疫苗提供新的见解。
Microb Biotechnol. 2024 Nov;17(11):e70053. doi: 10.1111/1751-7915.70053.

本文引用的文献

1
Shape Anisotropy-Governed High-Performance Nanomagnetosol for In Vivo Magnetic Particle Imaging of Lungs.用于肺部体内磁粒子成像的各向异性形状高性能纳米磁流体
Small. 2024 Feb;20(5):e2305300. doi: 10.1002/smll.202305300. Epub 2023 Sep 21.
2
The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells.纳米酶在癌症治疗中的应用:基于调控肿瘤细胞的细胞焦亡、铁死亡和自噬。
Nanoscale. 2023 Jul 27;15(29):12137-12156. doi: 10.1039/d3nr01722b.
3
The applications of nanozymes in neurological diseases: From mechanism to design.
纳米酶在神经疾病中的应用:从机制到设计。
Theranostics. 2023 Apr 23;13(8):2492-2514. doi: 10.7150/thno.83370. eCollection 2023.
4
Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance.免疫抑制性生物材料基治疗性疫苗通过重新建立免疫耐受来治疗多发性硬化症。
Nat Commun. 2022 Dec 2;13(1):7449. doi: 10.1038/s41467-022-35263-9.
5
Tolerogenic Nanovaccine for Prevention and Treatment of Autoimmune Encephalomyelitis.免疫耐受纳米疫苗防治自身免疫性脑脊髓炎。
Adv Mater. 2023 Jan;35(1):e2202670. doi: 10.1002/adma.202202670. Epub 2022 Nov 22.
6
PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets.聚乙二醇间隔物长度对基于抗体的纳米载体靶向树突状细胞亚群有显著影响。
Pharmaceutics. 2022 Aug 2;14(8):1614. doi: 10.3390/pharmaceutics14081614.
7
Antigen transfer and its effect on vaccine-induced immune amplification and tolerance.抗原转移及其对疫苗诱导免疫放大和耐受的影响。
Theranostics. 2022 Aug 1;12(13):5888-5913. doi: 10.7150/thno.75904. eCollection 2022.
8
Efficacy and Immune Response Elicited by Gold Nanoparticle- Based Nanovaccines against Infectious Diseases.基于金纳米颗粒的纳米疫苗针对传染病引发的功效及免疫反应
Vaccines (Basel). 2022 Mar 24;10(4):505. doi: 10.3390/vaccines10040505.
9
Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents.在啮齿动物创伤性脑损伤的控制性皮质撞击损伤模型中多层囊泡纳米颗粒在损伤脑组织中的定位
Neurotrauma Rep. 2022 Apr 5;3(1):158-167. doi: 10.1089/neur.2021.0049. eCollection 2022.
10
A chitosan-mediated inhalable nanovaccine against SARS-CoV-2.一种壳聚糖介导的抗SARS-CoV-2可吸入纳米疫苗。
Nano Res. 2022;15(5):4191-4200. doi: 10.1007/s12274-021-4012-9. Epub 2022 Feb 2.